SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001206774-10-001385
Filing Date
2010-06-02
Accepted
2010-06-02 16:00:31
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT regeneron_10ka.htm 10-K/A 95822
2 AMENDED AND RESTATED DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT exhibit10-14.htm EX-10.14 469970
3 AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT exhibit10-15.htm EX-10.15 728637
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) exhibit31-1.htm EX-31.1 3990
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) exhibit31-2.htm EX-31.2 4489
  Complete submission text file 0001206774-10-001385.txt   1304218
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19034 | Film No.: 10872890
SIC: 2834 Pharmaceutical Preparations